President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Popular weight loss drugs like ... been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said ...